← Back
$TVTX All transactions

Travere Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$105K

Shares

2,910

Price

$36

Filed

Dec 16

Insider

Name

Calvin Sandra

Title

SVP, CHIEF ACCOUNTING OFFICER

CIK

0001882909

Roles

Officer

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

45,635

Footnotes

This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Filing Info

Accession No.

0001882909-25-000006

Form Type

4

Issuer CIK

0001438533

Calvin Sandra's History

Date Ticker Type Value
2026-04-14 TVTX M $56K
2026-04-14 TVTX M $56K
2026-04-14 TVTX M $133K
2026-04-14 TVTX $903K
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0
2026-04-14 TVTX M $0
2025-12-24 TVTX $296K
2025-12-15 TVTX $105K
2025-11-04 TVTX M $252K

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15